14 August 2020
Russia plans to make 5 million doses of the coronavirus vaccine per month in December-January, Director of the Gamaleya National Research Center for Epidemiology and Microbiology Alexander Gintsburg told reporters on Wednesday.
“According to the schedule, [enterprises] are expected to reach their full capacity in December or January. <…>the capacity should be about 5 million per month, maybe even more. If that is the case, the entire country will be provided with the appropriate drug within a year,” he said.
On Tuesday, Russian President Vladimir Putin said that Russia had registered the world’s first COVID-19 vaccine. According to Health Minister Mikhail Murashko, the vaccine was developed by the Gamaleya National Research Center for Epidemiology and Microbiology.
Print14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Big Pharma’s ROI for drug R&D saw 'welcome' rebound in 2023: report
25 April 2024
Orphan drug market to reach $270B by 2028 : Evaluate
25 April 2024
Russian drug for the treatment of viral hepatitis will be exempt from duty in Mongolia
24 April 2024
PM Mishustin: “We need to increase the production of vital and essential drugs in Russia”
24 April 2024